No Data
No Data
Bronco Billy: Half Year Report - 43rd Period (2024/01/01 - 2024/12/31)
Bronco Billy: Confirmation letter
Stocks that moved the day before, part 1: NexTone, FLN, Shibaura Mechatronics, etc.
Full year metal <7826> 4555 +135, with performance underperforming but dividend increase highly regarded. Kitanihon Bouseki <3409> 101 +3, sales contract for the world's first charge-free smart tracker developed by a subsidiary of Medirom, which is listed on NASDAQ. Amazia <4424> 552 +80, speculation that manga app usage will increase due to the spread of the novel coronavirus and expectation of intense heat. FLN <9241> 1969 +219, introduces shareholder benefits program with only 1.
Bronco B, SE H&I, Good Product Plan, etc.
<4503> Astellas Pharma fell sharply by 55 to 1642. Jefferies Securities downgraded its investment rating from "buy" to "hold" and lowered its target stock price from 2100 yen to 1700 yen. Sales forecasts for overactive bladder treatment Mirabegron, hot flush treatment Veoza, and geographic atrophy treatment Izervay have been downwardly revised, and annual revenue estimates for the next five years are expected to decrease by an average of 5%. The EBITDA estimate appears to be about 9% below consensus. <7
Active and newly listed stocks during the morning session.
*Shibaura Mechatronics <6590>: 8780 +590. The rebound in the SOX index caused a strong backlash from the previous day's sharp decline. *Yamashin Filter <6240>: 522 +32 continues to be sought after as a Trump-related stock. *FP Partner <7388>: 3235 +170 maintains a predominant upward trend after the first half earnings report. *Ryohin Keikaku <7453>: 2825 +147.5 has its target stock price raised at Mizuho Securities. *Ezaki Glico <2206>: 4606 +203 has Dalton Investments become a major shareholder.
Hot stocks digest (morning): Fuji Pharma, Bronco B, WOLVES, etc.
Furuya Metal <7826>: up 85 yen to 4505 yen. The company announced a downward revision of its financial estimates the previous day, with operating profit for the fiscal year ending June 24 decreasing 15.5% from the previous year's estimate to 9.7 billion yen from 10.2 billion yen. The delay in the sales recovery of the thin film division and the fine chemical recycling department is believed to be the reason. However, there were strong concerns about lower-than-expected results based on the situation until the third quarter, and the negative reaction was limited. On the other hand, with the implementation of a commemorative dividend of 30 yen, the annual dividend is expected to be 256 yen as previously forecasted.
No Data